Skip to main content
This website uses cookies to ensure you get the best experience. By continuing to use this site, you agree to the use of cookies.

Please note: Your browser does not support the features used on Addgene's website. You may not be able to create an account or request plasmids through this website until you upgrade your browser. Learn more

Please note: Your browser does not fully support some of the features used on Addgene's website. If you run into any problems registering, depositing, or ordering please contact us at [email protected]. Learn more

Addgene

huCaV2.2 (pSAD442-1) Citations (2)

Originally described in: CACNA1B mutation is linked to unique myoclonus-dystonia syndrome.
Groen JL, Andrade A, Ritz K, Jalalzadeh H, Haagmans M, Bradley TE, Jongejan A, Verbeek DS, Nurnberg P, Denome S, Hennekam RC, Lipscombe D, Baas F, Tijssen MA Hum Mol Genet. 2015 Feb 15;24(4):987-993. Epub 2014 Oct 8.
PubMed Journal

Articles Citing huCaV2.2 (pSAD442-1)

Articles
Ca(v)2.2-NFAT2-USP43 axis promotes invadopodia formation and breast cancer metastasis through cortactin stabilization. Xue Y, Li M, Hu J, Song Y, Guo W, Miao C, Ge D, Hou Y, Wang X, Huang X, Liu T, Zhang X, Huang Q. Cell Death Dis. 2022 Sep 22;13(9):812. doi: 10.1038/s41419-022-05174-0. PubMed
The Interplay Between Splicing of Two Exon Combinations Differentially Affects Membrane Targeting and Function of Human Ca(V)2.2. Dahimene S, Page KM, Nieto-Rostro M, Pratt WS, Dolphin AC. Function (Oxf). 2023 Oct 19;5(1):zqad060. doi: 10.1093/function/zqad060. eCollection 2024. PubMed

If you have published an article using this material, please email us at [email protected] to have your article added to this page.